Search

Your search keyword '"Liau A"' showing total 941 results

Search Constraints

Start Over You searched for: Author "Liau A" Remove constraint Author: "Liau A" Publisher elsevier bv Remove constraint Publisher: elsevier bv
941 results on '"Liau A"'

Search Results

1. An autoinhibitory switch of the LSD1 disordered region controls enhancer silencing

2. PREDICTORS OF MUSCULOSKELETAL DISORDERS AMONG SPECIAL EDUCATION TEACHERS IN SABAH, MALAYSIA

4. The clinical characteristics of Malaysian patients with Takayasu Arteritis: A retrospective study of 3 decades

7. A Predictive Model for Musculoskeletal Disorders Among Special Education Teachers a Cross-Sectional Study

9. The precede consortium: A longitudinal international cohort study of individuals with a high-risk of pancreatic cancer

13. A Multicenter Prospective Randomized Comparison of Conduits Versus Decellularized Nerve Allograft for Digital Nerve Repairs

17. Clinicopathological characteristics and prognosis in significantly thick acral lentiginous melanoma in Taiwan

18. Children with Mycoplasma pneumoniae infection in Taiwan: Changes in molecular characteristics and clinical outcomes

19. Early derangement of INR predicts liver failure after liver resection for hepatocellular carcinoma

21. Localised Cdr1as activity is required for fear extinction memory

22. CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosis

23. Systematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ROS-sensing pathway

24. Surgical outcomes of gallbladder cancer: the OMEGA retrospective, multicentre, international cohort study

26. An update on inflammation in uveal melanoma

27. Filling a nick in NIK: extending the half-life of a NIK inhibitor through structure-based drug design

28. CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosis

31. Transcriptomic Analysis Identifies Synapse-Enriched lncRNAs Required for Excitatory Synapse Development and Fear Memory

33. Filling a Nick in NIK: Extending the Half-Life of a NIK Inhibitor Through Structure-Based Drug Design

34. Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial

35. Surgical outcomes of gallbladder cancer: the OMEGA retrospective, multicentre, international cohort study

37. Filling a Nick in NIK: Extending the Half-Life of a NIK Inhibitor Through Structure-Based Drug Design

38. Medication Management in Frail Older People: Consensus Principles for Clinical Practice, Research, and Education

39. Molecular diagnosis and therapy for cutaneous leishmaniasis of a returned traveler from Mexico

44. Early derangement of INR predicts liver failure after liver resection for hepatocellular carcinoma

45. A molecular interactome of the glioblastoma perivascular niche reveals integrin binding sialoprotein as a mediator of tumor cell migration

48. Systematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ROS-sensing pathway

49. Localised Cdr1as activity is required for fear extinction memory

50. CRAF dimerization with ARAF regulates KRAS-driven tumor growth.

Catalog

Books, media, physical & digital resources